Side effects across medicines

Medicines whose labels list fall

115 medicines have an FDA label that names fall in its boxed warning, warnings, adverse reactions, trial table, patient leaflet or Drug Facts “stop use” warning (of the labels PlainMeds reads: each medicine's quoted label and up to eight more, by route and wording). Among them, the most FAERS reports of fall name gabapentin (15,562), lenalidomide (7,514) and quetiapine (6,332), through July 30, 2026. A label lists what its studies and reports found, and a report does not show that a medicine caused the event.

Check it at the source: the FDA FAERS public dashboard; FDA labels on DailyMed.

Which medicines' labels list fall?

Ordered by where the label names it, the boxed warning first, then by FAERS reports. A medicine whose own indications name it, because it treats it, is not counted.

Medicine	Where a label names it	FAERS reports of fall
Lenalidomide	adverse reactions	7,514
Quetiapine	adverse reactions	6,332
Zolpidem	adverse reactions	5,636
Escitalopram	adverse reactions	5,577
Diazepam	adverse reactions	4,312
Pimavanserin	adverse reactions	4,005
Levetiracetam	adverse reactions	3,758
Sildenafil	adverse reactions	3,112
Duloxetine	adverse reactions	2,948
Risperidone	adverse reactions	2,824
Sacubitril and valsartan	adverse reactions	2,746
Clozapine	adverse reactions	2,730
Ibrutinib	adverse reactions	2,527
Sodium oxybate	adverse reactions	2,457
Aripiprazole	adverse reactions	2,122
Enzalutamide	adverse reactions	1,834
Rivastigmine	adverse reactions	1,744
Pomalidomide	adverse reactions	1,731
Droxidopa	adverse reactions	1,510
Letrozole	adverse reactions	1,497
Oxybutynin	adverse reactions	1,490
Lacosamide	adverse reactions	1,395
Tramadol	adverse reactions	1,292
Buprenorphine	adverse reactions (transdermal label)	1,268
Oxcarbazepine	adverse reactions	1,192
Valbenazine	adverse reactions	1,129
Rasagiline	adverse reactions	1,066
Ropinirole	adverse reactions	1,049
Abiraterone	adverse reactions	950
Tacrolimus	adverse reactions	920
Levodopa	adverse reactions	705
Botulinum toxin type a	adverse reactions	702
Haloperidol	adverse reactions (intramuscular label)	539
Siponimod	adverse reactions	511
Galantamine	adverse reactions	496
Calcium oxybate, magnesium oxybate, potassium oxybate and sodium oxybate	adverse reactions	394
Oxaliplatin	adverse reactions	381
Hydrocodone	adverse reactions	368
Brexpiprazole	adverse reactions	367
Lurasidone	adverse reactions	364
Apalutamide	adverse reactions	337
Canagliflozin	adverse reactions	329
Tetrabenazine	adverse reactions	319
Perindopril	adverse reactions	288
Aclidinium	adverse reactions	280
Suvorexant	adverse reactions	269
Opicapone	adverse reactions	258
Amifampridine	adverse reactions	238
Dronabinol	adverse reactions	230
Cytarabine	adverse reactions	229
Perampanel	adverse reactions	223
Agalsidase beta	adverse reactions	199
Fenfluramine	adverse reactions	195
Paliperidone	adverse reactions	186
Nusinersen	adverse reactions	175
Cariprazine	adverse reactions	145
Triazolam	adverse reactions	144
Abiraterone and niraparib	adverse reactions	none in the top 1,000
Apomorphine	adverse reactions	none in the top 1,000
Aripiprazole lauroxil	adverse reactions	none in the top 1,000
Asenapine	adverse reactions	none in the top 1,000
Brepocitinib	adverse reactions	none in the top 1,000
Cabazitaxel	adverse reactions	none in the top 1,000
Canagliflozin and metformin	adverse reactions	none in the top 1,000
Cedazuridine and decitabine	adverse reactions	none in the top 1,000
Cemiplimab	adverse reactions	none in the top 1,000
Cevimeline	adverse reactions	none in the top 1,000
Cobimetinib	adverse reactions	none in the top 1,000
Decitabine	adverse reactions	none in the top 1,000
Dichlorphenamide	adverse reactions	none in the top 1,000
Difelikefalin	adverse reactions	none in the top 1,000
Doxylamine and pyridoxine	adverse reactions	none in the top 1,000
Elranatamab	adverse reactions	none in the top 1,000
Entrectinib	adverse reactions	none in the top 1,000
Eslicarbazepine	adverse reactions	none in the top 1,000
Esomeprazole and naproxen	adverse reactions	none in the top 1,000
Estradiol and norethindrone and relugolix	adverse reactions	none in the top 1,000
Fluoxetine and olanzapine	adverse reactions	none in the top 1,000
Fluvoxamine	adverse reactions	none in the top 1,000
Formoterol and glycopyrrolate	adverse reactions	none in the top 1,000
Fosinopril	adverse reactions	none in the top 1,000
Golodirsen	adverse reactions	none in the top 1,000
Iloperidone	adverse reactions	none in the top 1,000
Imetelstat	adverse reactions	none in the top 1,000
Isavuconazonium	adverse reactions	none in the top 1,000
Lumateperone	adverse reactions	none in the top 1,000
Milsaperidone	adverse reactions	none in the top 1,000
Mirdametinib	adverse reactions	none in the top 1,000
Mitoxantrone	adverse reactions	none in the top 1,000
Mogamulizumab	adverse reactions	none in the top 1,000
Olanzapine and samidorphan l-malate	adverse reactions	none in the top 1,000
Pegzilarginase	adverse reactions	none in the top 1,000
Pirtobrutinib	adverse reactions	none in the top 1,000
Pivekimab sunirine	adverse reactions	none in the top 1,000
Repotrectinib	adverse reactions	none in the top 1,000
Rucaparib camsylate	adverse reactions	none in the top 1,000
Satralizumab	adverse reactions	none in the top 1,000
Tividenofusp alfa	adverse reactions	none in the top 1,000
Velmanase alfa-tycv	adverse reactions	none in the top 1,000
Vepdegestrant	adverse reactions	none in the top 1,000
Ziconotide	adverse reactions	none in the top 1,000
Ziprasidone	adverse reactions	none in the top 1,000
Amantadine	trial table	1,773
Gabapentin	patient leaflet	15,562
Mirtazapine	patient leaflet	4,168
Deutetrabenazine	patient leaflet	311
Vilazodone	patient leaflet	188
Amitriptyline and chlordiazepoxide	patient leaflet	none in the top 1,000
Bupropion and dextromethorphan	patient leaflet	none in the top 1,000
Clesrovimab	patient leaflet	none in the top 1,000
Daridorexant	patient leaflet	none in the top 1,000
Etripamil	patient leaflet	none in the top 1,000
Nirsevimab	patient leaflet	none in the top 1,000
Taletrectinib adipate	patient leaflet	none in the top 1,000
Zidesamtinib	patient leaflet	none in the top 1,000

Source: FDA drug labels via openFDA, read October 8, 2026; FAERS via openFDA, reports through July 30, 2026

Which of them have the most fall reports in FAERS?

Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; MedDRA preferred term “Fall”

What next?

Side effects across medicines: every reaction on PlainMeds
Report a side effect to the FDA: MedWatch